Position in CYTK
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$766,710
+$173,520 QoQ
Shares Held
9,000
0.0% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#279
of 477 holders
Holding Since
Mar 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Derivatives in CYTK
reported options exposure · as of Dec 31, 2025CallValue
$635,400
CallShares
10,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Carlson Capital, L.P. holds $2,624,930 across 3 Biotechnology names. CYTK ranks #2 (29.2% of the industry book) .
All Filings in CYTK
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $766,710 | 9,000 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $593,190 | 9,000 | Shares | Sole | 2026-05-28 | |
| 2025-12-31 | $635,400 | 10,000 | Call | Sole | 2026-02-03 | |
| 2025-12-31 | $355,824 | 5,600 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $258,312 | 4,700 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $677,320 | 20,500 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $301,425 | 7,500 | Shares | Sole | 2025-05-14 | |
| 2024-06-30 | $2,069,676 | 38,200 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,752,750 | 25,000 | Shares | Sole | 2024-05-14 | |
| No filing history on record for this holder in this stock. | ||||||